Abstract
Purpose of Review
This review aims to assess recent data on possible effective and safe complementary and integrative medicine (CIM) modalities that can be of help to patients affected by cancer that suffer from cancer-related fatigue (CRF).
Recent Findings
Cancer-related fatigue (CRF) is one of the most common, persistent, and challenging symptoms among cancer patients and survivors. Many world-leading cancer centers incorporate CIM into routine cancer care including integrating multiple approaches to address CRF. Approaches that are supported by clinical evidence on the use of CIM during and following conventional oncology treatments are being discussed in this review.
Summary
The review suggests that some CIM modalities might have a potential role in alleviating cancer-related fatigue. These modalities include acupuncture, touch therapies, nutrition, nutritional supplements, stress reduction, homeopathy, and circadian rhythm management. Additional research is still needed to better support the process of integrating CIM into a routine approach to cancer-related fatigue.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
• NCCN, Clinical Practice Guidelines in Oncology. Cancer-Related Fatigue Version 1 2021. (2020). Available: https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf. Accessed May 1 2021. An important and uptodate document that summarizes current knowledge and basic recommendations for addressing cancer-related fatigue both conventional care and some complementary and integrative options.
David DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer. 2008;16(7):791–801.
Hofman M, Ryan J, Figueroa-Moseley C, Jean-Pierre P and Morrow G. “Cancer-related fatigue: the scale of the problem”. Oncologist. 2007;12(Suppl 1).
Arring N, Barton D, Brooks T, Zick S. Integrative therapies for cancer-related fatigue. Cancer J. 2019;5(5):349–56.
Wu H, Harden J. Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs. 2015;38(1):E29-54.
Wang X, Zhao F, Fisch M, O’Mara A, Cella D, Mendoza T, Cleeland C. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014;120(3):425–32.
Saligan L, Olson K, Filler K, Larkin D, Cramp F, Yennurajalingam S, Escalante C, del Giglio A, Kober K, Kamath J, Palesh O and Mustian K. Multinational Association of Supportive Care in Cancer Fatigue Study Group-Biomarker Working Group. The biology of cancer-related fatigue: a review of the literature. Support Care Cancer. 2015;23(8).
Hampson J, Zick S, Khabir T, Wright B, Harris R. Altered resting brain connectivity in persistent cancer related fatigue. Neuroimage Clin. 2015;7(8):305–13.
Zick S, Zwickey H, Wood L, Foerster B. Preliminary differences in peripheral immune markers and brain metabolites between fatigued and non-fatigued breast cancer survivors: a pilot study. Brain Imaging Behav. 2014;8(4):506–16.
Finnegan-John J, Molassiotis A, Richardson A, Ream E. A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue. Integr Cancer Ther. 2013;12(4):276–90.
Mustian K, Alfano C, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;3(7):961–8.
• Deng GE, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integrative Oncol. 2009;7(3 (Summer)):85–120. An important document that summarizes the clinical practice guidelines for integrative oncology followed by most academic integrative oncology centers.
Plaisance E and Grandjean P. Physical activity and high-sensitivity C-reactive protein. Sports Med. 2006;36(5).
Dimeo F. Effects of exercise on cancer-related fatigue. Cancer. 2001;159(26 Suppl).
Al-Majid S and Gray DA. Biobehavioral model for the study of exercise interventions in cancer-related fatigue. Biol Res Nurs. 2009;10(4).
Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;11:CD006145.
Puetz T, Herring M. Differential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis. Am J Prev Med. 2012;43(2):e1-24.
Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–90.
Doyle C, Kushi LH, Byers T, Courneya KS, Demark-Wahnefried W, Grant B, McTiernan A, McTiernan A, Rock CL, Thompson C, Gansler T, Andrews KS. Nutrition and physical activity during and after cancer treatment: an American Cancer Society Guide for Informed Choices. CA Cancer J Clin. 2006;56:323–353
Schmitz KH, Stout NL, Maitin-Shepard M, Campbell A, Schwartz AL, Grimmett C, Meyerhardt JA, Sokolof JM. Moving through cancer: setting the agenda to make exercise standard in oncology practice. Cancer. 2020;127:476–84.
Johnson JA, Garland SN, Carlson LE, Simpson JSA, Ancoli-Israel S, Campbell TS. Bright light therapy improves cancer-related fatigue in cancer survivors: a randomized controlled trial. J Cancer Surviv. 2018;12(2):206–15.
Neikrug AB, Rissling M, Trofimenko V, Liu L, Natarajan L, Lawton S, Parker BA, Ancoli-Israel S. Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med. 2012;10(3):202–16.
Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Hamilton KK, Grant B, McCullough M, Byers T, Gansler V. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62:242–74.
Ferioli M, Zauli G, Martelli A, Vitale M, McCubrey JA, Ultimo S, Capitani S, Neri LM. Impact of physical exercise in cancer survivors during and after antineoplastic treatments. Oncotarget. 2018;9(17):14005–34.
Pan Y, Yang K, Wang Y, Zhang L, Liang H. Massage interventions and treatment-related side effects of breast cancer: a systematic review and meta-analysis. Int J Clin Oncol. 2014;19(5):829–41.
Sood A, Barton D, Bauer B and Loprinzi C. A critical review of complementary therapies for cancer-related fatigue. Integr Cancer Ther. 2007;6(1).
Tarrasch R, Carmel-Neiderman NN, Ben-Ami S, Kaufman B, Pfeffer R, Ben-David M, Gamus D. The effect of reflexology on the pain-insomnia-fatigue disturbance cluster of breast cancer patients during adjuvant radiation therapy. J Altern Complement Med. 2018;24(1):62–8.
Morhenn V, Beavin L, Zak P. Massage increases oxytocin and reduces adrenocorticotropin hormone in humans. Altern Ther Health Med. 2012;18(6):11–8.
Field T. Massage therapy research review. Complement Ther Clin Pract. 2014;20(4):224–9.
Adams RN, Mosher CE, Winger JG, Abonour R, Kroenke K. Cancer-related loneliness mediates the relationships between social constraints and symptoms among cancer patients. J Behav Med. 2018;41(2):243–52.
Tabatabaee A, Tafreshi MZ, Rassouli M, Aledavood S, AlaviMajd H, Farahmand SK. Effect of therapeutic touch in patients with cancer: a literature review. Med Arch. 2016;70(2):142–7.
Cassileth B and Vickers A. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage. 2004;28(3).
Post-White J, Kinney M, Savik K, Gau J, Wilcox C, Lerner I. Therapeutic massage and healing touch improve symptoms in cancer. Integr Cancer Ther. 2003;2(4):332–44.
Jang A, Brown C, Lamoury G, Morgia M, Boyle F, Marr V, Clarke S, Back V and Oh B. The effects of acupuncture on cancer-related fatigue: updated systematic review and meta-analysis. Integr Cancer Ther. 2020.
Garcia MK, Cohen L, Spano M, Spelman A, Hashmi Y, Chaoul A, Wei Q, Lopez G. Inpatient acupuncture at a major cancer center. Integr Cancer Ther. 2018;17(1):148–52.
Lopez G, Garcia MK, Liu W, Spano M, Underwood S, Dibaj SS, Li Y, Moguel R, Williams J, Bruera E, Cohen L. Outpatient acupuncture effects on patient self-reported symptoms in oncology care: a retrospective analysis. J Cancer. 2018;9(19):613–3619.
Zick SM, Sen A, Wyatt GK, Murphy SL, Arnedt JT, Harris RE. Investigation of 2 types of self-administered acupressure for persistent cancer-related fatigue in breast cancer survivors: a randomized clinical trial. JAMA Oncol. 2016;2(11):1470–6.
Montgomery G, Hallquist M, Schnur J, David D, Silverstein J, Bovbjerg D. Mediators of a brief hypnosis intervention to control side effects in breast surgery patients: Response expectancies and emotional distress. J Consult Clin Psychol. 2010;78(1):8.
Montgomery G, Schnur J, Kravits K. Hypnosis for cancer care: over 200 years young. CA Cancer J Clin. 2013;63(1):31–44.
Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM, Boyce LM, Tripathy D. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017;67:194–232.
Xie C, Dong B, Wang L, Jing X, Wu Y, Lin L, Tian L. Mindfulness-based stress reduction can alleviate cancer- related fatigue: a meta-analysis. J Psychosom Res. 2020;130:109916.
Grégoire C, Nicolas H, Bragard I, Delevallez F, Merckaert I, Razavi D, Waltregny D, Faymonville ME, Vanhaudenhuys A. Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients. BMC Cancer. 2018;18(1):677.
Kwekkeboom KL, Cherwin CH, Lee JW, Wanta B. Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage. 2010;39(1):126–38.
• Inglis JE, Lin PJ, Kerns SL, Kleckner IR, Kleckner AS, Castillo DA, Mustian KM, Peppone LJ. Nutritional interventions for treating cancer-related fatigue: a qualitative review. Nutr Cancer. 2019;71(1):21–40. An important document that addresses practical issues related to nutrition and cancer related fatigue.
Ryan AM, Power DG, Daly L, Cushen SJ, NíBhuachalla Ē, Prado CM. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc. 2016;75(2):199–211.
Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol. 2005;23(7):1431–8.
World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Update Project Expert Report 2018. Available at https://www.wcrf.org/dietandcancer/a-summary-of-the-third-expert-report/. Accessed May 1, 2021.
Zick SM, Colacino J, Cornellier M, Khabir T, Surnow K, Djuric Z. Fatigue reduction diet in breast cancer survivors: a pilot randomized clinical trial. Breast Cancer Res Treat. 2017;161(2):299–310.
Stobäus N, Müller MJ, Küpferling S, Schulzke JD, Norman K. Low recent protein intake predicts cancer-related fatigue and increased mortality in patients with advanced tumor disease undergoing chemotherapy. Nutr Cancer. 2015;67(5):818–24.
Pritlove C, Capone G, Kita H, Gladman S, Maganti M, Jones JM. Cooking for vitality: pilot study of an innovative culinary nutrition intervention for cancer-related fatigue in cancer survivors. Nutrients. 2002;12(9):2760.
Gröber U, Holzhauer P, Kisters K, Holick MF, Adamietz IA. Micronutrients in oncological intervention. Nutrients. 2016;8(3):163.
Ludwig H, Müldür E, Endle G, Hübl W. Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol. 2013;24(7):1886–92.
Frenkel M, Abrams DI, Ladas EJ, Deng G, Capodice JL, Winegardner MF, Gubili JK, Yeung KS, Kussmann HH, and Block KI. Integrating dietary supplements into cancer care. Integr Cancer Ther. 2013;369–84.
Palmer A, Zortea M, Souza A, Santos V, Biazús JV, Torres I, Fregni F and Caumo W. Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: a randomized, double-blind, placebo-controlled trial. PloS one 15(4).
Shilts J, Chen G, Hughey JJ. Evidence for widespread dysregulation of circadian clock progression in human cancer. PeerJ. 2018;6:e4327.
Innominato PF, Roche VP, Palesh OG, Ulusakarya A, Spiegel D, Lévi FA. The circadian timing system in clinical oncology. Ann Med. 2014;46(4):191–207.
Chen WY, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, Schernhammer ES. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat. 2014;145(2):381–8.
Wang YM, Jin BZ, Ai F, Duan CH, Lu YZ, Dong TF, Fu QL. The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials. Cancer Chemother Pharmacol. 2012;69(5):1213–20.
Innominato PF, Lim AS, Palesh O, Clemons M, Trudeau M, Eisen A, Wang C, Kiss A, Pritchard KI, Bjarnason GA. The effect of melatonin on sleep and quality of life in patients with advanced breast cancer. Support Care Cancer. 2016;24(3):1097–105.
Walach H, Jonas WB, Ives J, van Wijk R, Weingärtner O. Research on homeopathy: state of the art. J Altern Complement Med. 2005;11(5):813–29.
Bagot JL, Legrand A, Theunissen I. Use of homeopathy in integrative oncology in Strasbourg, France: multi-center cross-sectional descriptive study of patients undergoing cancer treatment. Homeopathy. 2021. https://doi.org/10.1055/s-0040-1721065.
Rostock M, Naumann J, Guethlin C, Guenther L, Bartsch HH and Walach H. Classical homeopathy in the treatment of cancer patients--a prospective observational study of two independent cohorts. BMC Cancer. 2011;11–19.
Frass M, Friehs H, Thallinger C, Sohal NK, Marosi C, Muchitsch I, Gaertner K, Gleiss A, Schuster E, Oberbaum M. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients - a pragmatic randomized controlled trial. Complement Ther Med. 2015;23(3):309–17.
Samuels N, Freed Y, Weitzen R, Ben-David M, Maimon Y, Eliyahu U, Berger R. Feasibility of homeopathic treatment for symptom reduction in an integrative oncology service. Integr Cancer Ther. 2018;17(2):486–92.
[Online]. Astragalus. About Herbs - Memorial Sloane Kettering Integrative Medicine Program. Available: https://www.mskcc.org/cancer-care/integrative-medicine/herbs/astragalus. Accessed May 1, 2021.
Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev. 2005;25(1):CD004540.
Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li XK, Tang W. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 2010;4(6):297–307.
Wang SF, Wang Q, Jiao LJ, Huang YL, Garfield D, Zhang J, Xu L. Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis. Curr Oncol. 2016;23(3):e188–95.
Wang CH, Lin CY, Chen JS, Ho CL, Rau KM, Tsai JT, Chang CS, Yeh SP, Cheng CF, Lai YL. Karnofsky performance status as a predictive factor for cancer-related fatigue treatment with astragalus polysaccharides (PG2) injection-a double blind, multi-center, randomized phase IV study. Cancers. 2019;11(2):128.
Huang WC, Kuo KT, Bamodu OA, Lin YK, Wang CH, Lee KY, Wang LS, Yeh CT, Tsai JT. Astragalus polysaccharide (PG2) ameliorates cancer symptom clusters, as well as improves quality of life in patients with metastatic disease, through modulation of the inflammatory cascade. Cancers (Basel). 2019;11(8):1054.
[Online]. Ginseng. About Herbs - Memorial Sloane Kettering Integrative Medicine Program. Available: https://www.mskcc.org/cancer-care/integrative-medicine/herbs/ginseng-asian#references-2. Accessed May 1, 2021.
Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999;58(11):1685–93.
Kim JW, Han SW, Cho JY, Chung IJ, Kim JG, Lee KH, Park KU, Baek SK, Oh SC, Lee MA, Oh D, Shim B, Ahn JB, Shin D, Lee JW and Kim YH. Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: a randomised phase III trial. 2020;May(130).
Sadeghian M, Rahmani S, Zendehdel M, Hosseini SA and Zare Javid A. Ginseng and cancer-related fatigue: a systematic review of clinical trials. 2020:1–12.
[Online]. Ashwagandha. About Herbs - Memorial Sloane Kettering Integrative Medicine Program. Available: https://www.mskcc.org/cancer-care/integrative-medicine/herbs/ashwagandha. Accessed May 1, 2021.
Frenkel M, Sapire K. Complementary and integrative medicine in hematologic malignancies: questions and challenges. Curr Oncol Rep. 2017;19(12):79.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical collection on Integrative Care
Rights and permissions
About this article
Cite this article
David, A., Hausner, D. & Frenkel, M. Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?. Curr Oncol Rep 23, 145 (2021). https://doi.org/10.1007/s11912-021-01135-6
Accepted:
Published:
DOI: https://doi.org/10.1007/s11912-021-01135-6